Search Results

Role of Lutetium Radioligand Therapy in Prostate Cancer.

• Authors : Książek, Ignacy; Ligęza, Artur; Drzymała, Franciszek

Subjects: NAUSEA -- Risk factors; RADIOISOTOPE therapy; CASTRATION-resistant prostate cancer

• Source: Cancers; Jul2024, Vol. 16 Issue 13, p2433, 15p

Record details

Lutetium DOTATATE whole body scans: A novel approach for evaluation of neuroendocrine tumors.

• Authors : Singh, Natasha ; Krishna, B. A.; Vyas, Madhusudan

Subjects: *NEUROENDOCRINE tumors; *LUTETIUM; *IMAGING of cancer

• Source: Indian Journal of Nuclear Medicine. Jul2011, Vol. 26 Issue 3, p135-138. 4p. 5 Color Photographs, 1 Black and White Photograph.

Record details

A Phase II Study of Lutetium Lu 177 Dotatate in Metastatic Prostate Cancer With Neuroendocrine Differentiation.

Subjects: PROSTATE cancer; LUTETIUM; METASTASIS

• Source: Hepatitis Weekly; 2/6/2023, p93-93, 1p

Record details

Targeted Therapy: New radiolabeled somatostatin analogs to treat gastroenteropancreatic neuroendocrine tumors.

• Authors : Boucher, Jean E. (NURSE); Sommers, Robin (NURSE)

Subjects: ANTINEOPLASTIC agents; ONCOLOGY nursing; MALIGNANT carcinoid syndrome

• Source: Clinical Journal of Oncology Nursing. Oct2018, Vol. 22 Issue 5, p565-568. 4p. 2 Charts.

Record details

Threshold for defining PSMA-positivity prior to 177Lu-PSMA therapy: a comparison of [68Ga]Ga-PSMA-11 and [18F]F-DCFPyL in metastatic prostate cancer.

• Authors : Heilinger, Jan; Weindler, Jasmin; Roth, Katrin Sabine

Subjects: METASTASIS; PROSTATE cancer; POSITRON emission tomographyBASEL (Switzerland)EUROPEAN Medicines Agency; NOVARTIS AG

• Source: EJNMMI Research; 9/20/2023, Vol. 13 Issue 1, p1-11, 11p

Record details

Should Lutetium-prostate specific membrane antigen radioligand therapy for metastatic prostate cancer be used earlier in men with lymph node only metastatic prostate cancer?

• Authors : Yaxley, William John; McBean, Rhiannon; Wong, David

Subjects: CASTRATION-resistant prostate cancer; PROSTATE cancer; METASTASIS

• Source: Investigative & Clinical Urology; Nov2021, Vol. 62 Issue 6, p650-657, 8p

Record details

Large-scale synthesis of PEGylated lutetium hydroxycarbonates as nanoparticulate contrast agents for X-ray CT imaging.

• Authors : Zhaogui Ba; Yumin Zhang; Junpei Wei

Subjects: ELECTROMAGNETIC waves; LUTETIUM compounds; COMPUTED tomography

• Source: New Journal of Chemistry; 2015, Vol. 39 Issue 1, p589-594, 6p

Record details

O-06 Efficacy of Lutetium-Peptide Receptor Radionuclide Therapy and osilodrostat treatment at achiving eucortisolism and tumour stabilization in a patient with metastatic ectopic ACTH-syndrome.

• Authors : Khandaeva, Patimat; Golounina, Olga; Feidorov, Ilia

Subjects: ADRENAL insufficiency; LEUKOCYTE count; SOMATOSTATIN receptors

• Source: JCEM Case Reports; 2024 Supplement, Vol. 2, p1-2, 2p

Record details

Current state of theranostics in metastatic castrate‐resistant prostate cancer.

• Authors : Nindra, Udit (AUTHOR); Lin, Peter (AUTHOR); Becker, Therese (AUTHOR)

Subjects: UNITED States. Food & Drug Administration; PROSTATE cancer; CLINICAL trials

• Source: Journal of Medical Imaging & Radiation Oncology. Jun2024, Vol. 68 Issue 4, p412-420. 9p.

Record details

Radionuklidtherapie des Prostatakarzinoms mittels PSMA-Lutetium.

• Authors : Heck, M.; Retz, M.; Tauber, R.

Subjects: ANTIGENS; CHEMICAL elements; DRUG therapy

• Source: Der Urologe A; Jan2017, Vol. 56 Issue 1, p32-39, 8p

Record details